Botulinum toxin for depression: Does patient appearance matter?

J Am Acad Dermatol. 2016 Jan;74(1):171-173.e1. doi: 10.1016/j.jaad.2015.08.051.
No abstract available

Publication types

  • Letter

MeSH terms

  • Botulinum Toxins, Type A / therapeutic use*
  • Depressive Disorder, Major / diagnosis*
  • Depressive Disorder, Major / drug therapy*
  • Facial Expression
  • Female
  • Follow-Up Studies
  • Humans
  • Injections, Subcutaneous
  • Male
  • Neuromuscular Agents / therapeutic use*
  • Prospective Studies
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A